Gene · 54888
Papers1,406
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,406
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic and post-translational regulatory networks of ferroptosis in the tumor immune microenvironment. | Exp Hematol Oncol | 2026 | 41588554 | PubTator, text mining | PubMed |
| All-Trans Retinoic Acid Suppresses Hepatocellular Carcinoma Progression via the CSTB/CYTB Axis. | J Cell Mol Med | 2026 | 41578084 | PubTator, text mining | PubMed |
| Integrative analysis of nanopore direct RNA sequencing data reveals a global impact of pseudouridylation on m6A and m5C modifications. | NPJ Precis Oncol | 2026 | 41571893 | PubTator, text mining | PubMed |
| Beyond metabolism: exploring the regulatory and therapeutic implications of lactate and lactylation in cancer-regulated cell death. | Cell Death Dis | 2026 | 41571623 | PubTator, text mining | PubMed |
| NSUN2 restrains gastric cancer cell apoptosis and ferroptosis by promoting the m5C modification of EPYC. | Hereditas | 2026 | 41549314 | PubTator, text mining | PubMed |
| Unveiling the landscape of m5C RNA methylation in lung cancer: From molecular mechanisms to therapeutic opportunities. | Biochem Biophys Res Commun | 2026 | 41519051 | PubTator, text mining | PubMed |
| NSUN2-engineered human umbilical cord mesenchymal stem cell-derived exosomes ameliorate tendon injury by promoting DNM2 expression. | Regen Ther | 2026 | 41503520 | PubTator, text mining | PubMed |
| Oncogenic and immunological roles of NSUN2 in triple negative breast cancer. | Sci Rep | 2026 | 41495094 | PubTator, text mining | PubMed |
| NSUN2 activated by KLF6 can mediate m5C modification of NCOA4 to enhance ferroptosis of OGD/R-induced SH-SY5Y cells in ischemic stroke. | Biochim Biophys Acta Mol Cell Res | 2026 | 41478321 | PubTator, text mining | PubMed |
| Lactylation-driven NSUN2-mediated RNA m5C modification promotes perineural invasion in pancreatic cancer. | Theranostics | 2026 | 41356184 | PubTator, text mining | PubMed |
| MZF1-AS1/NSUN2 promotes the peritoneal metastasis of gastric cancer by enhancing the stability of RAB13 mRNA. | Gastric Cancer | 2026 | 41343127 | PubTator, text mining | PubMed |
| DUX4-induced HSATII RNA accumulation drives protein aggregation, impacting RNA processing pathways. | J Cell Biol | 2026 | 41329166 | PubTator, text mining | PubMed |
| NCAPG confers ferroptosis resistance of hepatocellular carcinoma through NSUN2-mediated m5C modification. | Cell Signal | 2026 | 41260238 | PubTator, text mining | PubMed |
| NSUN2 Promotes Prostate Cancer Cell Proliferation and Migration Through m5C Modifications of YES1. | Mol Carcinog | 2026 | 41176634 | PubTator, text mining | PubMed |
| NSUN2 promotes the growth, metastasis, and glutamine metabolism of non-small cell lung cancer. | Am J Respir Cell Mol Biol | 2026 | 41086397 | PubTator, text mining | PubMed |
| The oncogenic role of NSUN2 in lung adenocarcinoma by stabilizing CCT5 mRNA via a YBX1-dependent m5C modification. | Mol Cell Biochem | 2026 | 40928583 | PubTator, text mining | PubMed |
| RNA-m5C regulatory atlas of human fetal tissues uncover the activities of Nsun2/Jarid2/Alyref axis. | J Adv Res | 2026 | 40784520 | PubTator, text mining | PubMed |
| NSUN2 Knockdown Promotes the Ferroptosis of Colorectal Cancer Cells Via m5C Modification of SLC7A11 mRNA. | Biochem Genet | 2026 | 39920526 | PubTator, text mining | PubMed |
| The Role of NSUN Family Genes in m5C Methylation and Diseases. | Biomedicines | 2025 | 41462962 | PubTator, text mining | PubMed |
| NSUN2 mediated-aberrant 5-methylcytosine methylation regulates autophagy-related ferroptosis in oral squamous cell carcinoma progression. | Cell Death Dis | 2025 | 41436732 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54888/papers?page=5